Impoyz Approval History
Impoyz (clobetasol propionate) is a high potency topical corticosteroid indicated for the treatment of moderate to severe plaque psoriasis.
Development History and FDA Approval Process for Impoyz
|Dec 1, 2017||Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.